Breaking News: PPLPHARMA Next 200 Target
ICICI Securities Re-Initiates Coverage on Piramal Pharma with Buy Rating - 22 Dec, 2023. Piramal Pharma Ltd's stock surges over 8% to hit a 52-week high of Rs 140.20 on the BSE after ICICI Securities re-initiated coverage with a buy rating and set a target price of Rs 180.
cup and handle pattern you can see weekly chart why i say 200 targethttps://www.tradingview.com/x/ng1YC5Ac/
cup and handle pattern you can see weekly chart why i say 200 targethttps://www.tradingview.com/x/ng1YC5Ac/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.